作者: Paul W. Harms , Rajiv M. Patel , Monique E. Verhaegen , Thomas J. Giordano , Kevin T. Nash
DOI: 10.1038/JID.2012.445
关键词:
摘要: Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine tumor with high mortality rates. polyomavirus (MCPyV), identified in the majority of MCCs, may drive tumorigenesis via viral T antigens. However, mechanisms underlying pathogenesis MCPyV-negative MCCs remain poorly understood. To nominate genes contributing to we performed DNA microarray analysis on 30 MCCs. The MCPyV status was determined by PCR for and RNA. A total 1,593 probe sets were differentially expressed between MCPyV-positive significant differential expression defined as at least a 2-fold change either direction P-value p0.05. tumors showed decreased RB1 expression, whereas enriched immune response genes. Validation studies included immunohistochemistry demonstration RB protein increased peritumoral CD8 þ lymphocytes surrounding tumors. In conclusion, our data suggest that loss have important role Functional clinical validation are needed determine whether this tumorsuppressor pathway represents avenue targeted therapy.